CompuGROUP Opts for Clarity of Economic Prescriptions

CompuGROUP Holding AGCompuGROUP Holding AG, a leading European provider of eHealth solutions, opts for a law suit to obtain clarity regarding the legitimacy of implementation regulations pertaining to pharma advertising in information systems for doctors pursuant to the AVWG (German law for the economic provision of pharmaceutical products). While the company fully supports the goal of reaching the highest possible levels of transparency and freedom from manipulation, it also considers the currently existing regulations according to the AVWG to be sufficient. Moreover, it perceives elaboration details of the respective legal phrases to be substantially deficient.

CompuGROUP wishes to see the new legal certification obligation thoroughly examined, because here bureaucracy seems to be at work without the need for it: In the past, various lurid publications about this issue have hit the media, but no violations of the law or any abuses could be verified. One thing is clear: Doctors shall receive all information contributing to economic and medically indicated prescriptions in the context of their usual workflow. The newly published regulations regarding a possible certification by the KBV (National Association of Statutory Health Insurance Physicians) confirm that this certification obligation is not only redundant, but also counterproductive, i.e. cost-increasing.

From CompuGROUP's point of view, the law itself, which has been in effect since 2006, constitutes an illegal, direct invasion of doctors' freedom of scope in organizing their work and of the used software. This impression has been affirmed by the latest requirements issued by KBV. If the certification becomes obligatory, doctors will have to give up important aspects of their accustomed electronic mapping of daily work routines, or once again they will be all lumped together. Such an overregulation is – as is becoming clear already – far in excess of reaching the initial goal. Many useful functions, e.g. the mapping of discount contracts, will no longer be feasible in their customary form.

"We explicitly welcome the creation of an information framework for economic prescriptions, but unfortunately the introduction of a certification regulation by the legislator had the exact opposite effect: It is a serious invasion of the doctors' workflow organization and the software's use – a software doctors have deliberately chosen for economic and medical reasons, and one that has helped them doing their work for years. This is why we are now seeking a conclusive legal decision," explains CompuGROUP board member Jan Broer. "The pharma information in this software makes an important contribution to economic prescription behavior. Not least for this reason the prescription rate of generic drugs is so high, especially in Germany. It is actually extremely high here compared to other European countries."

As early as in 2006, the majority of the information systems for doctors industry had taken the initiative, as part of a voluntary undertaking, to offer advertising-free software versions on the one hand and to label advertising clearly as such on the other. "As a matter of fact, for a long time we have been doing more than the legislator asked for in the AVWG. For the recurrent debating of this issue, one fact alone must be blamed: There are a few market participants who pursue personal interests and exploit both politics and the media to gain competitive advantages, thus eventually hurting the healthcare system," emphasizes Broer.

Jan Broer stated that in spite of the fact that legal aid has been requested, the door will remain open for a further dialogue between the industry and KBV. He adds: "Of course we support an initiative that aims at concretizing already existent regulations. Yet it is inacceptable that these regulations constitute a violation of the freedom of scope in the development of our software. Our request has for the most part been met with understanding and approval by the involved parties."

Related news articles:

About CompuGROUP Holding AG
CompuGROUP is one of the leading eHealth companies in Europe. Its software products, designed to support all medical and organizational activities in doctors' surgeries and hospitals, its information services for all involved parties within the healthcare system and its web-based personal health records contribute to safer and more efficient healthcare. The services of CompuGROUP are centered on its unique customer base of around 300,000 doctors, dentists, hospitals, associations and networks as well as other service providers. CompuGROUP operates in 9 European countries and currently employs around 1,800 people.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...